Renovaro Biosciences (RENB) - 2019 Q2 - Quarterly Report

U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FORM 10-Q For the quarterly period ended December 31, 2018 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________ Commission file number 000-54478 Enochian Biosciences, Inc. (Exact name of registrant as specified in its charter) | Delaware | 45-2259340 | | --- | --- | ...